Roche Holding Ltd. (ROG) Receives CHF 271.08 Consensus PT from Analysts

Shares of Roche Holding Ltd. (VTX:ROG) have received a consensus rating of “Hold” from the fourteen ratings firms that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating on the company. The average 1-year price objective among analysts that have covered the stock in the last year is CHF 271.08.

A number of research firms recently issued reports on ROG. Kepler Capital Markets set a CHF 231 price objective on Roche Holding and gave the stock a “neutral” rating in a report on Tuesday, June 6th. Deutsche Bank AG set a CHF 273 price objective on Roche Holding and gave the stock a “buy” rating in a report on Tuesday, June 6th. HSBC Holdings plc set a CHF 215 price objective on Roche Holding and gave the stock a “sell” rating in a report on Tuesday, June 6th. Goldman Sachs Group, Inc. (The) set a CHF 335 price objective on Roche Holding and gave the stock a “buy” rating in a report on Tuesday, June 6th. Finally, Jefferies Group LLC set a CHF 305 price objective on Roche Holding and gave the stock a “buy” rating in a report on Monday, May 29th.

Shares of Roche Holding (VTX:ROG) traded down 0.08% during midday trading on Friday, hitting CHK 247.20. The stock had a trading volume of 1,051,824 shares. The company has a market capitalization of CHK 210.93 billion and a PE ratio of 21.95. The firm’s 50-day moving average is CHK 245.91 and its 200 day moving average is CHK 251.86. Roche Holding has a one year low of CHK 218.30 and a one year high of CHK 273.00.

TRADEMARK VIOLATION NOTICE: This article was first published by BBNS and is the property of of BBNS. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US and international trademark and copyright legislation. The original version of this article can be viewed at https://baseballnewssource.com/markets/roche-holding-ltd-rog-receives-chf-271-08-consensus-pt-from-analysts-updated/1409662.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with our FREE daily email newsletter.

 


Latest News

Kris Bryant Back in Spotlight, Cubs Pushing for Playoff Berth
Kris Bryant Back in Spotlight, Cubs Pushing for Playoff Berth
Despite Changes to Reduce The Length of Games, MLB Games are Actually Getting Longer
Despite Changes to Reduce The Length of Games, MLB Games are Actually Getting Longer
Despite Hitting Home Run, Judge Sets Longest Game Streak for Strikeouts
Despite Hitting Home Run, Judge Sets Longest Game Streak for Strikeouts
Los Angeles Dodgers Move 50 Games Over .500
Los Angeles Dodgers Move 50 Games Over .500
Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Bryce Harper Latest Star to Suffer Injury
Bryce Harper Latest Star to Suffer Injury


Leave a Reply

 
© 2006-2017 BBNS.